Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Short Communication - Journal of Cancer Clinical Research (2018) Volume 1, Issue 2

Potential of ellagic acid mediated enhanced radiosensitivity of breast tumor cells to Î? radiation in improving cancer radiotherapy

Kaushala Prasad Mishra

Bhabha Atomic Research Center, India

Visit for more related articles at Journal of Cancer Clinical Research


It is a common observation that radiosensitive tumor can be better cured than a radioresistant tumor which is generally accompanied by local recurrence and metastasis. Therefore, the goal of increasing tumor radiosensitivity continues to occupy a central focus in research. Herbal polyphenols have been receiving increasing importance because they enhance radiosensitivity of a variety of tumor cells mainly involving the modulation of intracellular signaling mechanisms. This presentation describes the effect of the flavonoid, ellagic acid (EA), on ? irradiated breast cancer cell line in vitro. Studies from our laboratory have shown that EA produced a radioprotective effect on NIH 3T3, a model of the normal cell by the mechanism of facilitating recovery from radiation damage. On the other hand, irradiation of tumor cells in presence of EA (10?M) to doses of 2 and 4Gy of ? radiation produced marked synergistic tumor cytotoxicity in MCF-7 cells. A combined treatment of EA and radiation increased cellular death by 21.7 and 20.7% to 2 and 4Gy respectively. Further studies showed increased apoptosis in EA+2Gy and EA+4 Gy treated cells in the sub G1 phase of the cell cycle together with the up-regulation of pro-apoptotic Bax and down-regulation of Bcl-2 in the cells. Moreover, the combined treatment of EA and IR produced a 6.2 fold decrease in the mitochondrial membrane potential. It is concluded that EA may be a potential drug adjuvant for increasing tumor toxicity and reducing the normal cell damage relevant for improving cancer radiotherapy.

Keywords: Radiation, Tumor, Breast, Ellagic Acid, Radiosensitivity

Brief Description

Medicines which repress or hinder movement of the cell through the cell cycle have been accounted for to lessen the viability of ionizing radiation by expanding cell radioresistance. We examined cell radiosensitivity and radiation-instigated DNA harm (twofold strand break, dsb) in both hormone-touchy and non-delicate human breast malignant growth cell lines. After 72h of culture in an oestradiol-denied medium, MCF-7 BUS and T47D B8 breast malignant growth cells indicated a critical postponement in development, though no impact was seen in EVSA-T cell line. In without oestradiol medium, MGF-7 BUS cells were captured essentially in G(zero)/G1 stage (85-90% in G(zero)/G1, 5-7% in S, and 6-8% in G2/M). The development postponed MCF-7 BUS cells demonstrated diminished radiosensitivity (endurance division at 2 Gy, SF2 = 63%; starting DNA harm 1.00 dsb/Gy/DNA unit) in examination with multiplying cells (SF2 = 33%, beginning DNA harm 2.70 dsb/Gy/DNA unit). The radio-defensive impact of estrogen hardship was annulled by protecting MCF-7 cells with estrogen-containing medium. At 24h after salvage, MCF-7 BUS cells arrived at a cell cycle dissemination near that found under standard culture conditions and their radiosensitivity was correspondingly expanded (SF2 = 40%, DNA harm = 2.52 dsb/Gy/DNA unit). Our discoveries demonstrate that: (1) affectability to radiation and the extent of multiplying cells are likely related, and (2) contrasts in radiosensitivity reflect contrasts in radiation-instigated DNA harm.


All in all, breast malignancies are the most well-known types of disease in ladies with over 1.676 million new conclusions worldwide every year . Since the presentation of national screening programs, powerful clinical organizing, sub-atomic conclusion along with proficient treatment regimens, the endurance of patients with breast disease has improved essentially In the United Kingdom. Radiotherapy is a significant part of multimodal treatment for ladies with beginning period (I and II) breast malignant growth. In the UK all ladies ought to be offered radiotherapy following medical procedure or chemotherapy and National Institute for Health Care Excellence (NICE) rules suggest fractionated radiotherapy of 40 Gy radiation in 15 parts. The intracellular protein kinase Brk (otherwise called breast tumor kinase or protein tyrosine kinase 6, PTK6) has been ensnared in the turn of events and movement of various distinctive tumor types including breast malignancy and is over-communicated in 80% of a wide range of breast disease. In this examination we wished to decide the connection between Brk oncogene over-articulation and radiation affectability in breast malignant growth cell lines. Brk has been demonstrated to be up-managed and overexpressed in up to 80% of ductal breast carcinomas yet as of not long ago was not thought to be communicated in typical breast tissue . Brk is a non-film bound tyrosine kinase and has been exhibited to connect with various key intracellular cell flagging proteins which lead to expanded cell endurance, upgraded cell movement and raised multiplication]; be that as it may, the effect of Brk articulation on cell radiation affectability and DNA DSB fix has not been assessed. Past investigations don't uncover any immediate connection of Brk with DNA fix forms in breast malignant growth, despite the fact that Brk articulation has been connected to guideline of apoptosis in light of DNA harming specialists in non-tumor cells . Likewise raised Brk articulation prompts expanded ErbB flagging by means of PI3-K/AKT , an upstream activator of the mTOR (mammalian objective of rapamycin) pathway . PI3-K/AKT/mTOR is considered as a possible remedial objective in breast malignant growth. Besides, raised mTOR flagging is known to stifle the ataxia telangiectasia changed protein (ATM) articulation by actuating microRNAs focusing on ATM for demolition . ATM is a key cell cycle controller and mutational inactivation prompts extraordinary cell and clinical affectability to radiation. In this manner we may guess that expanded Brk articulation in breast malignant growth cells may influence the reaction of breast disease cells to radiation by means of the ATM pathway. To inspect the connection between cell reaction to ionizing radiation and Brk articulation in breast malignant growth cells we dissected the reaction of two gatherings of breast disease cell lines. The triple negative breast disease cell lines

Cells were plated into 10 cm dishes at groupings of 2×106 cells/dish (for the assurance of DNA DSB by γ−η2αξ enlistment) and 4×106 cells/dish (for the recognizable proof of aggregate or phosphorylated ataxia telangiectasia protein levels), and left for the time being in a hatchery (conditions depicted beforehand). One dish of every cell line was held as an un-illuminated control; the rest of the dishes were lighted with 2 Gy gamma radiation from a 60Cobalt source (Puridec) sited a ways off of 25 cm with a portion pace of 0.8 Gy every moment. Two Gray gamma illumination was picked to compare to fractionated dosages of radiation utilized in clinical conventions. We have likewise shown beforehand that the acceptance of DNA DSB by 2 Gy gamma illumination speaks to a locale of maximal γ−η2αξ enlistment [20]. Following presentation the cells were come back to the hatchery (brooding conditions portrayed beforehand), and one dish evacuated at 30 minutes, 3 hours, 5 hours and 24 hours after light. Cells in each dish were reaped, washed once with super cold PBS (Severn Biotech Ltd., Worcestershire, UK) and fixed in super cold methanol:acetone (50:50 v/v). Two pay tests for imaging stream cytometry were set up similarly at the 30 moment timepoint. Tests were put away at −20°C until the immunocytochemistry stage. The immunocytochemistry initiated inside 5 days of light. Immunocytochemistry – gamma H2AX test Cells were re-suspended in super cold PBS at that point fomented delicately for 5 minutes at room temperature in permeabilisation cushion comprising of 0.5% Triton™ X-100 (Sigma-Aldrich Ltd) in PBS. Cells were hatched with delicate unsettling at room temperature for 1 hour in blocking support comprising of 5.0% bunny serum (Labtech) with 0.1% Triton™ X-100 in PBS. After the expulsion of the blocking support thecells were hatched for 24 hrs with delicate tumult at 4°C inessential immune response arrangement, comprising of an enemyof phospho-histone H2AX (serine139) mouse monoclonal IgG1counter acting agent, clone JBW301 (Millipore Ltd., Watford, UK)weakened 1 of every 10,000 in blocking cushion. Overabundanceessential counter acting agent was evacuated by washing twicein support comprising of 0.1% Triton™ X-100 in PBS. Essentialimmunizer named cells were hatched in optional counter actingagent arrangement comprising of Alexa Fluor® 488 hare hostileto mouse IgG neutralizer (Invitrogen) weakened 1 of every 1000in blocking support. This was added to each example, aside fromthe DRAQ5™ (Biostatus Ltd., Leicester, UK) pay tests, andhatched with delicate disturbance for 1 hour at room temperature.Abundance auxiliary counter acting agent was expelled by washing twice with wash cushion. The cells were resuspended in 100 μl.Accumax™ arrangement (Labtech) and left for the time being at4°C (no disturbance). Five μμ DRAQ5™ arrangement was addedto each example, with the exception of the AlexaFluor® 488 paytests. The pictures of in any event 10,000 cells for each time pointwere gathered by imaging stream cytometry.